Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
McCreary et al., Scientific Reports, doi:10.1038/s41598-022-13920-9
https://c19early.org/mccreary3.html